Methylprednisolone Terminated Phase 4 Trials for Immune Reconstitution Inflammatory Syndrome / Progressive Multifocal Leukoencephalopathy Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01211665Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)